Seroprevalence of SARS-CoV-2–Specific Antibodies: Faroe Islands

Maria Skaalum Petersen, Marin Strøm, Debes Hammershaimb Christiansen, Jógvan Páll Fjallsbak, Eina Eliasen, Malan Johansen, Anna Sofía Veyhe, Marnar Fríðheim Kristiansen, Shahin Gaini, Lars Fodgaard Møller, Bjarni á Steig, Pál Weihe

Research output: Contribution to journalArticlepeer-review

22 Citations (Scopus)


We conducted a nationwide study of the prevalence of severe acute respiratory syndrome coronavirus 2 infection in the Faroe Islands. Of 1,075 randomly selected participants, 6 (0.6%) tested seropositive for antibodies to the virus. Adjustment for test sensitivity and specificity yielded a 0.7% prevalence. Our findings will help us evaluate our public health response.
Original languageEnglish
Pages (from-to)2760-2762
Number of pages3
JournalEmerging Infectious Diseases
Issue number11
Publication statusPublished - Nov 2020


  • SARS-CoV-2
  • antibodies
  • Faroe Islands


Dive into the research topics of 'Seroprevalence of SARS-CoV-2–Specific Antibodies: Faroe Islands'. Together they form a unique fingerprint.

Cite this